Skip to main content

Clinical trial lidERA

A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with physician's choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive, her2-negative early breast cancer.

Cancers
Organ Breast
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor Roche
EudraCT Identifier 2021-000129-28
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT04961996
Last update